Evernorth, the health services division of The Cigna Group (NYSE: CI) announced a first-of-its-kind pharmacy benefit offering that make weight loss medications WEGOVY® and ZEPBOUND® more ...

Blue Cross plans are retreating from GLP-1 weight-loss drug coverage after spending hundreds of millions of dollars on the ...

Jason R. Smith, Pharm.D., appointed as chief pharmacy officer in February 2025 for the University of Rochester Medical Center ...

Shares in Eli Lilly have weakened after CVS Health, one of the largest pharmacy benefit managers (PBMs) in the US, said it would no longer cover its obesity therapy Zepbound. The shares closed ...

Eli Lilly is claiming another victory in a head-to-head trial comparing its weight-loss drug Zepbound to its main rival Wegovy from Novo Nordisk. The full data from the 751-subject SURMOUNT-5 ...

and Zepbound for obesity. It also provides oncology products, including Alimta, Cyramza, Erbitux, Jaypirca, Retevmo, Tyvyt, and Verzenio. In addition, the company offers Olumiant for rheumatoid ...

Many online pharmacies offer Rybelsus, provided you have a valid prescription from a licensed healthcare professional, such as a primary care physician, endocrinologist, or nurse practitioner ...

Missing a dose of Ozempic may cause several side effects, including constipation, extreme hunger, diarrhea, and nausea, and increase the risk of diabetes complications. Missing an occasional dose ...

Wesco International (NYSE:WCC) shares lost ground at Friday’s opening. The Pittsburgh-based company leading provider of business-to-business distribution, logistics services and supply chain ...